Givaudan | GIVN - Cost Of Sales

Stock Price
2,793.00
Daily Change
-3.00 -0.11%
Monthly
-1.27%
Yearly
-23.86%
Q2 Forecast
2,645.61

Givaudan reported CHF2.07B in Cost of Sales for its fiscal semester ending in December of 2025.





Cost Of Sales Change Date
Air Liquide EUR 5.9B 415.5M Dec/2025
Akzo Nobel EUR 1.44B 84M Dec/2025
Anheuser-Busch USD 6.6B 38M Sep/2025
Arkema EUR 1.79B 12M Dec/2025
BASF EUR 10.93B 241M Dec/2025
Bayer EUR 4.5B 194M Dec/2025
Beiersdorf EUR 2.06B 50M Dec/2025
British American Tobacco GBP 3.6B 427M Dec/2025
Covestro EUR 2.7B 5.39B Dec/2025
Croda International GBP 445.5M 221.15M Dec/2024
Danone EUR 6.74B 59M Jun/2025
Diageo GBP 4.08B 166M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.68B 38.37M Dec/2025
Givaudan CHF 2.07B 105M Dec/2025
Heineken EUR 12.71B 288M Dec/2025
Henkel EUR 4.96B 110M Dec/2025
International Flavors Fragrances USD 1.83B 24M Dec/2025
Johnson Matthey GBP 5.04B 513M Dec/2025
Lonza CHF 2.28B 189M Jun/2025
L'Oréal EUR 5.62B 71.8M Dec/2025
Merck EUR 2.29B 183M Dec/2025
Nestle CHF 25.08B 1.48B Dec/2025
Pernod Ricard EUR 2.14B 99M Dec/2025
Reckitt Benckiser GBP 2.75B 1.34B Dec/2024
SGS CHF 445M 522M Jun/2025
Sika AG CHF 2.77B 49.8M Dec/2025
Solvay EUR 860M 71M Dec/2025
Umicore EUR 8.22B 4.83B Jun/2025
Victrex GBP 80M 3.8M Dec/2025